Illumina (ILMN) Revenue & Revenue Breakdown

Overview ForecastOwnership Financials Chart Transcripts

Illumina Revenue Highlights

Latest Revenue (Y)

$4.37B

Latest Revenue (Q)

$1.06B

Main Segment (Y)

Core Illumina

Main Geography (Y)

Americas

Illumina Revenue by Period

Illumina Revenue by Year

Date	Revenue	Change
2024-12-29	$4.37B	-2.93%
2023-12-31	$4.50B	-1.75%
2023-01-01	$4.58B	1.28%
2022-01-02	$4.53B	39.73%
2021-01-03	$3.24B	-8.58%
2019-12-29	$3.54B	6.30%
2018-12-30	$3.33B	21.11%
2017-12-31	$2.75B	14.74%
2017-01-01	$2.40B	8.05%
2016-01-03	$2.22B	19.25%
2014-12-28	$1.86B	30.97%
2013-12-29	$1.42B	23.74%
2012-12-30	$1.15B	8.81%
2012-01-01	$1.06B	16.93%
2011-01-02	$902.74M	35.48%
2010-01-03	$666.32M	16.24%
2008-12-28	$573.23M	56.28%
2007-12-30	$366.80M	98.71%
2006-12-31	$184.59M	151.13%
2006-01-01	$73.50M	45.31%
2005-01-02	$50.58M	80.43%
2003-12-28	$28.04M	179.23%
2002-12-29	$10.04M	303.86%
2001-12-30	$2.49M	89.90%
2000-12-31	$1.31M	176.17%
1999-12-31	$474.03K	-

Illumina generated $4.37B in revenue during NA 2024, up -2.93% compared to the previous quarter, and up 123.40% compared to the same period a year ago.

Illumina Revenue by Quarter

Date	Revenue	Change
2025-06-29	$1.06B	1.73%
2025-03-30	$1.04B	-5.71%
2024-12-29	$1.10B	2.22%
2024-09-29	$1.08B	-2.88%
2024-06-30	$1.11B	3.35%
2024-03-31	$1.08B	-4.10%
2023-12-31	$1.12B	0.27%
2023-10-01	$1.12B	-4.85%
2023-07-02	$1.18B	8.19%
2023-04-02	$1.09B	0.37%
2023-01-01	$1.08B	-2.87%
2022-10-02	$1.11B	-4.04%
2022-07-03	$1.16B	-4.99%
2022-04-03	$1.22B	2.09%
2022-01-02	$1.20B	8.12%
2021-10-03	$1.11B	-1.60%
2021-07-04	$1.13B	3.02%
2021-04-04	$1.09B	14.69%
2021-01-03	$953.00M	20.03%
2020-09-27	$794.00M	25.43%
2020-06-28	$633.00M	-26.31%
2020-03-29	$859.00M	-9.77%
2019-12-29	$952.00M	4.96%
2019-09-29	$907.00M	8.23%
2019-06-30	$838.00M	-0.95%
2019-03-31	$846.00M	-2.42%
2018-12-30	$867.00M	1.64%
2018-09-30	$853.00M	2.77%
2018-07-01	$830.00M	6.14%
2018-04-01	$782.00M	0.51%
2017-12-31	$778.00M	8.96%
2017-10-01	$714.00M	7.85%
2017-07-02	$662.00M	10.70%
2017-04-02	$598.00M	-3.45%
2017-01-01	$619.35M	2.01%
2016-10-02	$607.14M	1.17%
2016-07-03	$600.12M	4.96%
2016-04-03	$571.76M	-3.34%
2016-01-03	$591.55M	7.50%
2015-09-27	$550.27M	2.02%
2015-06-28	$539.38M	0.15%
2015-03-29	$538.57M	5.11%
2014-12-28	$512.38M	6.61%
2014-09-28	$480.63M	7.39%
2014-06-29	$447.57M	6.37%
2014-03-30	$420.78M	8.64%
2013-12-29	$387.33M	8.56%
2013-09-29	$356.80M	3.09%
2013-06-30	$346.09M	4.57%
2013-03-31	$330.96M	7.01%
2012-12-30	$309.26M	8.18%
2012-09-30	$285.87M	1.88%
2012-07-01	$280.61M	2.87%
2012-04-01	$272.77M	9.08%
2012-01-01	$250.07M	6.19%
2011-10-02	$235.50M	-18.07%
2011-07-03	$287.45M	1.75%
2011-04-03	$282.51M	8.12%
2011-01-02	$261.30M	10.11%
2010-10-03	$237.31M	11.94%
2010-07-04	$212.00M	10.34%
2010-04-04	$192.13M	6.41%
2010-01-03	$180.56M	14.02%
2009-09-27	$158.36M	-2.03%
2009-06-28	$161.64M	-2.48%
2009-03-29	$165.76M	3.00%
2008-12-28	$160.93M	7.10%
2008-09-28	$150.26M	7.19%
2008-06-29	$140.18M	15.03%
2008-03-30	$121.86M	-

Illumina generated $1.06B in revenue during Q2 2025, up 1.73% compared to the previous quarter, and up 98.42% compared to the same period a year ago.

Illumina Revenue Breakdown

Illumina Revenue Breakdown by Product

Annual Revenue by Product

Product/Service	Dec 23	Jan 23	Jan 22	Jan 21	Dec 19
Core Illumina	$4.44B	$4.55B	$4.52B	-	-
Microarray	$392.00M	-	-	-	-
GRAIL, Inc.	$93.00M	$55.00M	$12.00M	-	-
Sequencing	$4.11B	-	-	-	-
Consolidated Variable Interest Entities	-	-	-	-	-
Service, Other	-	-	-	$220.00M	$240.00M
Product	-	-	-	$788.00M	$802.00M

Illumina's latest annual revenue breakdown by segment (product or service), as of Dec 23: Core Illumina (49.12%), Sequencing (45.51%), Microarray (4.34%), and GRAIL, Inc. (1.03%).

Quarterly Revenue by Product

Product/Service	Jun 25	Mar 25	Sep 24	Mar 24	Dec 23	Jul 23	Apr 23	Jan 23	Oct 22	Jul 22	Apr 22	Jan 22	Oct 21	Jul 21	Apr 21	Jan 21	Sep 20	Jun 20	Mar 20	Dec 19
Sequencing	$972.00M	$947.00M	$995.00M	$979.00M	$1.09B	$1.01B	$1.02B	$979.00M	-	-	-	-	-	-	-	-	-	-	-	-
Microarray	$87.00M	$94.00M	$85.00M	$97.00M	$105.00M	$93.00M	$105.00M	$114.00M	-	-	-	-	-	-	-	-	-	-	-	-
Product	-	-	-	$876.00M	$831.00M	$812.00M	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Instruments	-	-	-	$114.00M	$145.00M	$147.00M	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Service	-	-	-	$200.00M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Consumables	-	-	-	$762.00M	$686.00M	$665.00M	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Core Illumina	-	-	-	-	$2.20B	$1.16B	$1.08B	$1.07B	$1.11B	$1.16B	$1.22B	-	-	-	-	-	-	-	-	-
GRAIL, Inc.	-	-	-	-	$51.00M	$22.00M	$20.00M	$23.00M	$10.00M	$12.00M	$10.00M	-	-	-	-	-	-	-	-	-
Service, Other	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$122.00M	$118.00M	$106.00M	$158.00M	$140.00M

Illumina's latest quarterly revenue breakdown by segment (product or service), as of Jun 25: Sequencing (91.78%), and Microarray (8.22%).

Illumina Revenue Breakdown by Country

Annual Revenue by Country

Country	Dec 24	Dec 23	Jan 23	Jan 22	Jan 21
Asia Pacific	$438.00M	$459.00M	$418.00M	$377.00M	$267.00M
CHINA	$308.00M	$384.00M	$472.00M	$502.00M	$342.00M
EMEA	$1.19B	$1.14B	$1.22B	$1.29B	$886.00M
UNITED STATES	$2.29B	$2.36B	$2.29B	$2.19B	$1.66B
Americas	$2.44B	$2.52B	$2.48B	$2.36B	$1.74B
Europe	-	$1.14B	-	-	-

Illumina's latest annual revenue breakdown by geography, as of Dec 24: Americas (36.65%), UNITED STATES (34.35%), EMEA (17.79%), Asia Pacific (6.58%), and CHINA (4.62%).

Quarterly Revenue by Country

Country	Jun 25	Mar 25	Dec 24	Sep 24	Mar 24	Dec 23	Jul 23	Apr 23	Jan 23	Oct 22	Jul 22	Apr 22	Jan 22	Oct 21	Jul 21	Apr 21	Jan 21	Sep 20	Jun 20	Mar 20
Asia Pacific	$100.00M	$106.00M	$94.00M	$95.00M	$97.00M	$132.00M	$103.00M	$90.00M	$85.00M	$99.00M	$77.00M	$62.00M	$51.00M	$77.00M	-	-	-	-	-	-
CHINA	$63.00M	$72.00M	$155.00M	$75.00M	$78.00M	$178.00M	$115.00M	$91.00M	$94.00M	$133.00M	$118.00M	$127.00M	$120.00M	$122.00M	$132.00M	$127.00M	$96.00M	$83.00M	$79.00M	$84.00M
EMEA	$310.00M	$293.00M	$615.00M	$291.00M	$279.00M	$301.00M	$290.00M	$308.00M	$316.00M	$351.00M	$313.00M	$320.00M	$305.00M	$284.00M	$213.00M	$168.00M	$221.00M	-	-	-
Americas	$586.00M	$570.00M	$1.23B	$609.00M	$603.00M	$1.26B	$640.00M	$616.00M	$594.00M	$597.00M	$639.00M	$648.00M	$625.00M	$583.00M	$589.00M	$562.00M	$496.00M	$436.00M	$335.00M	$477.00M
Europe	-	-	-	-	$279.00M	$576.00M	$303.00M	$261.00M	-	-	-	-	-	-	-	-	-	-	-	-

Illumina's latest quarterly revenue breakdown by geography, as of Jun 25: Americas (55.34%), EMEA (29.27%), Asia Pacific (9.44%), and CHINA (5.95%).

Illumina Peer Comparison by Revenue

Ticker	Company	Last Year Revenue	Last Quarter Revenue
TMO	Thermo Fisher Scientific	$42.88B	$10.86B
DHR	Danaher	$23.88B	$5.94B
REGN	Regeneron Pharmaceuticals	$14.20B	$3.68B
VRTX	Vertex Pharmaceuticals	$11.02B	$2.96B
BIIB	Biogen	$9.68B	$2.65B
ISRG	Intuitive Surgical	$8.35B	$2.44B
A	Agilent	$6.83B	$1.74B
ILMN	Illumina	$4.37B	$1.06B
GH	Guardant Health	$739.02M	$232.09M
CRSP	CRISPR Therapeutics	$37.31M	$892.00K

ILMN Revenue FAQ

What is Illumina’s yearly revenue?

Illumina's yearly revenue for 2024 was $4.37B, representing a decrease of -2.93% compared to 2023. The company's yearly revenue for 2023 was $4.5B, representing a decrease of -1.75% compared to 2022. ILMN's yearly revenue for 2022 was $4.58B, representing an increase of 1.28% compared to 2021.

What is Illumina’s quarterly revenue?

Illumina's quarterly revenue for Q2 2025 was $1.06B, a 1.73% increase from the previous quarter (Q1 2025), and a -4.77% decrease year-over-year (Q2 2024). The company's quarterly revenue for Q1 2025 was $1.04B, a -5.71% decrease from the previous quarter (Q4 2024), and a -3.25% decrease year-over-year (Q1 2024). ILMN's quarterly revenue for Q4 2024 was $1.1B, a 2.22% increase from the previous quarter (Q3 2024), and a -1.60% decrease year-over-year (Q4 2023).

What is Illumina’s revenue growth rate?

Illumina's revenue growth rate for the last 3 years (2022-2024) was -4.62%, and for the last 5 years (2020-2024) was 34.98%.

What are Illumina’s revenue streams?

Illumina's revenue streams in c 23 are Core Illumina, Microarray, GRAIL, Inc., and Sequencing. Core Illumina generated $4.44B in revenue, accounting 49.12% of the company's total revenue, down -2.53% year-over-year. Microarray generated $392M in revenue, accounting 4.34% of the company's total revenue GRAIL, Inc. generated $93M in revenue, accounting 1.03% of the company's total revenue, up 69.09% year-over-year. Sequencing generated $4.11B in revenue, accounting 45.51% of the company's total revenue

What is Illumina’s main source of revenue?

For the fiscal year ending Dec 23, the largest source of revenue of Illumina was Core Illumina. This segment made a revenue of $4.44B, representing 49.12% of the company's total revenue.